Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Proposed Reg Offers Doctors More Discreet Way To Report Adverse Events

This article was originally published in The Tan Sheet

Executive Summary

The number of adverse event reports available for public analysis could increase under a rule proposed by the Department of Health and Human Services

You may also be interested in...



Current MedWatch Form Stays While More Changes Could Occur Later In 2008

Substantive changes to FDA's MedWatch forms could come from the agency's MedWatch Plus program as soon as later this year

FDA, NIH Developing Online AER Portal Accessible To Other Federal Agencies

FDA and the National Institutes of Health are cooperating to create online portals for adverse event reporting that each agency can use to further its own current venture to improve AER quality, lower costs and reduce delivery time

FDA Eyes Upclassification, Labeling Guidance To Address Stapler Risks

The US agency sent a letter to health-care providers spotlighting its analysis of the increasing numbers of adverse events linked to surgical staplers and implantable staples, and its plans for a draft guidance on labeling and an advisory panel meeting to consider a 510(k) requirement for the products.

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS101400

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel